Technical Analysis for RNAZ - TransCode Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
Spinning Top | Other | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Below Lower BB | Weakness | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Down 4 Days in a Row | Weakness | 0.00% | |
Down 5 Days in a Row | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | about 4 hours ago |
Rose Above Previous Day's High | about 4 hours ago |
Rose Above Lower Bollinger Band | about 4 hours ago |
Up 5% | about 4 hours ago |
Up 3% | about 4 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/30/2023
TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs for the treatment of metastatic diseases. The company's lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. Its products in discovery and preclinical stage include MicroRNA-10b, TTX-siPDL1, TTX-siLIN28b, and TTX-RIGA, which focuses on treating various cancers. The company was incorporated in 2016 and is based in Boston, Massachusetts
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Preclinical Stage Product Metastatic Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Preclinical Stage Product Metastatic Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 356.0 |
52 Week Low | 0.47 |
Average Volume | 387,066 |
200-Day Moving Average | 25.73 |
50-Day Moving Average | 0.67 |
20-Day Moving Average | 0.64 |
10-Day Moving Average | 0.61 |
Average True Range | 0.06 |
RSI (14) | 23.08 |
ADX | 48.85 |
+DI | 8.30 |
-DI | 34.50 |
Chandelier Exit (Long, 3 ATRs) | 0.52 |
Chandelier Exit (Short, 3 ATRs) | 0.66 |
Upper Bollinger Bands | 0.76 |
Lower Bollinger Band | 0.53 |
Percent B (%b) | -0.11 |
BandWidth | 35.85 |
MACD Line | -0.08 |
MACD Signal Line | -0.09 |
MACD Histogram | 0.0034 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.59 | ||||
Resistance 3 (R3) | 0.59 | 0.57 | 0.58 | ||
Resistance 2 (R2) | 0.57 | 0.54 | 0.57 | 0.57 | |
Resistance 1 (R1) | 0.53 | 0.53 | 0.52 | 0.53 | 0.57 |
Pivot Point | 0.51 | 0.51 | 0.50 | 0.51 | 0.51 |
Support 1 (S1) | 0.48 | 0.48 | 0.46 | 0.47 | 0.44 |
Support 2 (S2) | 0.45 | 0.47 | 0.45 | 0.43 | |
Support 3 (S3) | 0.42 | 0.45 | 0.43 | ||
Support 4 (S4) | 0.41 |